OmniAb (OABI) Receivables - Other (2023 - 2026)
OmniAb's (OABI) quarterly Receivables - Other came in at $3.5 million in Q1 2026, up 400.0% year-on-year from $700000.0 in Q1 2025, and up 337.5% on a QoQ basis from $800000.0 in Q4 2025.
OmniAb (OABI) Receivables - Other (2023 - 2026) Analysis & Trends
OmniAb (OABI) has 4 years of Receivables - Other data on file, last reported at $3.5 million in Q1 2026.
- On a quarterly basis, Receivables - Other rose 400.0% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $3.5 million, a 400.0% increase from a year earlier, with the FY2025 full-year figure at $800000.0, down 69.23% from the prior year.
- Receivables - Other for Q1 2026 stood at $3.5 million, up from $800000.0 in the prior quarter.
- Over the last five years, Receivables - Other for OABI reached as high as $3.5 million in Q1 2026 and fell as low as $300000.0 in Q3 2025.
- Historically, Receivables - Other has averaged $1.3 million across 4 years, with a median of $800000.0 in 2023.
- Across the five-year window, Receivables - Other tumbled 69.23% in 2025 and soared 400.0% in 2026, its largest moves.
- Year by year, Receivables - Other stood at $800000.0 in 2023, then soared by 225.0% to $2.6 million in 2024, then tumbled by 69.23% to $800000.0 in 2025, then soared by 337.5% to $3.5 million in 2026.
- Per Business Quant data, the three most recent Receivables - Other figures were $3.5 million in Q1 2026, $800000.0 in Q4 2025, and $300000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.50 Mn |
| Mar 31, 2026 | 3.50 Mn |
| Dec 31, 2025 | 800,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | 800,000.00 |
| Dec 31, 2023 | 800,000.00 |